Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Jacksonville › NPI 1225577760
Physician

Cleanslate Medical Group of Florida, PLLC

Cleanslate Medical Group of Florida, PLLC was paid $79K by Medicaid between Jan 2019 and Jun 2020, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 76% of everything it billed.

33Billing provider infoCLEANSLATE MEDICAL GROUP OF FLORIDA, PLLC
JACKSONVILLE, FL 32206
33aNPI1225577760assigned 02/16/2017
28Total paid$79K
24GClaims4,092
24DCodes billed7
24AFirst – last monthJan 2019 – Jun 2020
Box 24A · Dates of service

Paid by month

$0$2.5K$5.0K$7.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20192,996$56K
20201,096$23K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 76% 2,504 1,170 $60K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 11% 499 317 $9K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8.1% 345 230 $6K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3.8% 150 132 $3K
Q3014 Telehealth originating site facility fee <1% 68 61 $760.78
81025 <1% 347 282 $498.55
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 179 146 $48.15

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHUTCHISON, ROBERT (CFO)
Same official

Other billing entities under HUTCHISON, ROBERT

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.